{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:21:09Z","timestamp":1790000469321,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.vaccine.2016.03.055","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T01:45:44Z","timestamp":1458697544000},"page":"2334-2341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Carrier priming effect of CRM 197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM 197 and diphtheria toxoid"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Pecetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Faenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cioncada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2016.03.055_bib0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nri3694","article-title":"From empiricism to rational design: a personal perspective of the evolution of vaccine development","volume":"14","author":"De Gregorio","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6976.2006.00051.x","article-title":"Conquering the meningococcus","volume":"31","author":"Stephens","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2016.03.055_bib0265","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/adc.2005.072173","article-title":"Conjugate vaccines","volume":"90","author":"Finn","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2016.03.055_bib0270","first-page":"628963","article-title":"Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines","author":"Klein Klouwenberg","year":"2008","journal-title":"Clin Dev Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.03.055_bib0275","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/648964","article-title":"Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines","volume":"50","author":"Poland","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.055_bib0280","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1517\/17460441.2011.609554","article-title":"The design of semi-synthetic and synthetic glycoconjugate vaccines","volume":"6","author":"Costantino","year":"2011","journal-title":"Expert Opin Drug Discov"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.055_bib0285","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nm.2587","article-title":"A sweet T cell response","volume":"17","author":"Rappuoli","year":"2011","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.055_bib0290","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1128\/IAI.67.12.6375-6384.1999","article-title":"Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines","volume":"67","author":"Guttormsen","year":"1999","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.055_bib0295","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.055_bib0300","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/infdis\/168.3.663","article-title":"Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines","volume":"168","author":"Granoff","year":"1993","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.055_bib0305","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4049\/jimmunol.135.4.2319","article-title":"Carrier-induced epitopic suppression, a major issue for future synthetic vaccines","volume":"135","author":"Schutze","year":"1985","journal-title":"J Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2016.03.055_bib0310","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.055_bib0315","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.145.5.1343","article-title":"The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression","volume":"145","author":"Leclerc","year":"1990","journal-title":"J Immunol"},{"issue":"33","key":"10.1016\/j.vaccine.2016.03.055_bib0320","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"Jegerlehner","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.055_bib0325","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.142.8.2635","article-title":"Carrier-induced epitopic suppression is initiated through clonal dominance","volume":"142","author":"Schutze","year":"1989","journal-title":"J Immunol"},{"issue":"34","key":"10.1016\/j.vaccine.2016.03.055_bib0330","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"issue":"7166","key":"10.1016\/j.vaccine.2016.03.055_bib0335","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.055_bib0340","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.03.055_bib0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.127.2.277","article-title":"Antigens in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles","volume":"127","author":"Nossal","year":"1968","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.055_bib0350","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ni.1946","article-title":"B cell follicles and antigen encounters of the third kind","volume":"11","author":"Cyster","year":"2010","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.055_bib0355","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ni957","article-title":"Antigen presentation to naive CD4 T cells in the lymph node","volume":"4","author":"Itano","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2016.03.055_bib0360","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1980.tb01039.x","article-title":"The follicular dendritic cell: long term antigen retention during immunity","volume":"53","author":"Mandel","year":"1980","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.03.055_bib0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-4615-2930-9_77","article-title":"Follicular dendritic cells in germinal center reactions","volume":"329","author":"Tew","year":"1993","journal-title":"Adv Exp Med Biol"},{"issue":"14","key":"10.1016\/j.vaccine.2016.03.055_bib0370","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"Malito","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.vaccine.2016.03.055_bib0375","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2013.07.078","article-title":"Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines","volume":"31","author":"Tontini","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.03.055_bib0380","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vaccine.2014.11.026","article-title":"Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation","volume":"33","author":"Pecetta","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0385","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/iid3.3","article-title":"Optimized fluorescent labeling to identify memory B cells specific for Neisseria meningitidis serogroup B vaccine antigens ex vivo","volume":"1","author":"Nair","year":"2013","journal-title":"Immun Inflamm Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2016.03.055_bib0390","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1016\/j.vaccine.2012.04.020","article-title":"One dose of an MF59-adjuvanted pandemic A\/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies","volume":"30","author":"Faenzi","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.055_bib0395","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.1402604","article-title":"Oil-in-water emulsion MF59 increases germinal center B cell differentiation and persistence in response to vaccination","volume":"195","author":"Lofano","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.055_bib0400","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.1400623","article-title":"Vaccine adjuvant MF59 promotes retention of unprocessed antigen in lymph node macrophage compartments and follicular dendritic cells","volume":"194","author":"Cantisani","year":"2015","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2016.03.055_bib0405","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.4049\/jimmunol.0900164","article-title":"Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity","volume":"183","author":"McKee","year":"2009","journal-title":"J Immunol"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2016.03.055_bib0410","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0264-410X(00)00261-9","article-title":"Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines","volume":"19","author":"Ho","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.055_bib0415","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.055_bib0420","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"Costantino","year":"1992","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0425","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1586\/erv.12.137","article-title":"Preclinical evaluation of MenB vaccines: prerequisites for clinical development","volume":"12","author":"Sanders","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"6585","key":"10.1016\/j.vaccine.2016.03.055_bib0435","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20100354","article-title":"Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cells","volume":"208","author":"McCloskey","year":"2011","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2016.03.055_bib0445","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.4049\/jimmunol.145.8.2397","article-title":"Clonal anergy of memory B cells in epitope-specific regulation","volume":"145","author":"Galelli","year":"1990","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2016.03.055_bib0450","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.161.2.702","article-title":"Carrier-induced, hapten-specific suppression: a problem of antigen presentation?","volume":"161","author":"Renjifo","year":"1998","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2016.03.055_bib0455","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.vaccine.2006.12.033","article-title":"Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin","volume":"25","author":"Thaysen-Andersen","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.055_bib0460","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1128\/IAI.62.5.1830-1834.1994","article-title":"Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing","volume":"62","author":"di Tommaso","year":"1994","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2016.03.055_bib0465","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2011.05.004","article-title":"Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications","volume":"39","author":"Broker","year":"2011","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.vaccine.2016.03.055_bib0470","first-page":"77","article-title":"Can animal models predict protection provided by meningococcal vaccines?","volume":"3","author":"Finney","year":"2006","journal-title":"Drug Discov Today: Dis Models"},{"issue":"3","key":"10.1016\/j.vaccine.2016.03.055_bib0475","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.vaccine.2007.11.042","article-title":"Immune responses to polysaccharides: lessons from humans and mice","volume":"26","author":"Gonzalez-Fernandez","year":"2008","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.055_bib0480","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2016.03.055_bib0485","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.055_bib0490","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo(R)) or Menactra(R) among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2016.03.055_bib0495","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.vaccine.2008.11.065","article-title":"Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa","volume":"27","author":"Lee","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.03.055_bib0500","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T05:42:10Z","timestamp":1692250930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":50,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0264410X1630038X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.055","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}